Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105712918B reveals a high-yield lactam synthesis using synergistic catalysis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel patent CN104211644B enables high-yield production. Offers supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN102249937A details a low-cost, non-toxic synthesis for Ivabradine intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN105085495B reveals a cost-effective one-pot method for N-alkynyl benzimidazole derivatives, ensuring high purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN108997247A discloses efficient oxidation route for Rivaroxaban intermediate enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN100478333C reveals a novel route for chiral bis-imidazolinylbenzene compounds using amino alcohols, offering cost-effective solutions for asymmetric catalysis ligands.
Patent CN112159380B discloses a safe, low-temperature route for Barosavir intermediates, eliminating toxic reagents and enabling cost reduction in API manufacturing.
Patent CN104326987B reveals water-phase catalytic synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Novel copper catalyzed route offers high yield quinoline amides. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel chromium-free oxidation route for high-purity diacerein production ensuring cost efficiency and supply chain stability.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Patent CN116041222B reveals safer midazolam synthesis. High purity, reduced steps, scalable for pharmaceutical intermediates supply chain efficiency.
Patent CN110590780B reveals a novel copper-catalyzed route for Linagliptin intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel copper-catalyzed oxidation method for CDK 4/6 inhibitor intermediates. High yield, low cost, scalable process for pharmaceutical manufacturing supply chains.
Patent CN107646037A reveals a novel succinimide-based route for Sofosbuvir intermediates, offering improved selectivity and supply chain stability for pharmaceutical manufacturers.
Novel one-pot two-step method using Iron(II) phthalocyanine for high-purity pharmaceutical intermediates with reduced costs and enhanced supply chain reliability.
Novel four-step synthesis of Sarpyridan using DMF and ammonium iodide. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier solutions.
Patent CN114605308A details a scalable synthesis of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane using dihalo-acyl chloride cyclization, offering significant cost and safety advantages.
Patent CN111057087B reveals a novel synthesis for asymmetric thiophene[7]helicene isomers, offering superior mobility for OLEDs and organic semiconductors with scalable manufacturing.
Patent CN102718695B reveals a mild, high-yield route for aza-bicyclo[3.3.0]octane derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.